JP2021525067A5 - - Google Patents
Info
- Publication number
- JP2021525067A5 JP2021525067A5 JP2020564146A JP2020564146A JP2021525067A5 JP 2021525067 A5 JP2021525067 A5 JP 2021525067A5 JP 2020564146 A JP2020564146 A JP 2020564146A JP 2020564146 A JP2020564146 A JP 2020564146A JP 2021525067 A5 JP2021525067 A5 JP 2021525067A5
- Authority
- JP
- Japan
- Prior art keywords
- cell
- manipulated
- immune cells
- seq
- sequence
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862675525P | 2018-05-23 | 2018-05-23 | |
| US62/675,525 | 2018-05-23 | ||
| PCT/US2019/033837 WO2019226946A1 (en) | 2018-05-23 | 2019-05-23 | Chimeric antigen receptors and gene editing of cd2 for immunotherapy of t-cell malignancies |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021525067A JP2021525067A (ja) | 2021-09-24 |
| JPWO2019226946A5 JPWO2019226946A5 (https=) | 2022-05-25 |
| JP2021525067A5 true JP2021525067A5 (https=) | 2022-05-25 |
Family
ID=68617214
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020564146A Pending JP2021525067A (ja) | 2018-05-23 | 2019-05-23 | Ｔ細胞悪性腫瘍の免疫療法のためのキメラ抗原受容体およびｃｄ２の遺伝子編集 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20210214439A1 (https=) |
| EP (1) | EP3784777A4 (https=) |
| JP (1) | JP2021525067A (https=) |
| CN (1) | CN112166186A (https=) |
| SG (1) | SG11202101094TA (https=) |
| WO (1) | WO2019226946A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20210008408A (ko) | 2018-05-23 | 2021-01-21 | 싱가포르국립대학교 | T-세포 악성 종양의 면역요법을 위한 cd2 표면 발현 및 키메라 항원 수용체의 발현에 대한 차단 |
| KR20210091250A (ko) * | 2018-11-14 | 2021-07-21 | 메디식스 테라퓨틱스 피티이 엘티디. | Car-t 세포를 생성하기 위한 이중유전자 벡터 및 이의 용도 |
| CN113667773A (zh) * | 2021-08-19 | 2021-11-19 | 南昌艾迪康医学检验实验室有限公司 | 检测CarT细胞中是否存在RCL污染的引物、探针及试剂盒 |
| EP4568685A2 (en) * | 2022-08-11 | 2025-06-18 | Medisix Therapeutics, Inc. | Engineered immune cells expressing a car and a plurality of protein expression blockers and uses thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7237449B2 (ja) * | 2015-02-27 | 2023-03-13 | アイセル・ジーン・セラピューティクス・エルエルシー | 血液系腫瘍を標的としたキメラ抗体受容体（ＣＡＲｓ）の構成およびその使用方法 |
| EP3294342A4 (en) * | 2015-05-08 | 2018-11-07 | President and Fellows of Harvard College | Universal donor stem cells and related methods |
| NZ750256A (en) * | 2016-08-03 | 2026-02-27 | Dipersio John F | Gene editing of car-t cells for the treatment of t cell malignancies with chimeric antigen receptors |
-
2019
- 2019-05-23 WO PCT/US2019/033837 patent/WO2019226946A1/en not_active Ceased
- 2019-05-23 JP JP2020564146A patent/JP2021525067A/ja active Pending
- 2019-05-23 CN CN201980034713.0A patent/CN112166186A/zh active Pending
- 2019-05-23 EP EP19808214.1A patent/EP3784777A4/en not_active Withdrawn
- 2019-05-23 SG SG11202101094TA patent/SG11202101094TA/en unknown
- 2019-05-23 US US17/057,978 patent/US20210214439A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110268049B (zh) | 用于t细胞恶性肿瘤免疫疗法的cd7表达阻滞剂和嵌合抗原受体 | |
| Dai et al. | Chimeric antigen receptors modified T-cells for cancer therapy | |
| Dougan et al. | Immune therapy for cancer | |
| US20240197884A1 (en) | Compositions and methods for targeted tumor immunotherapy | |
| JP2022003043A (ja) | 養子ｔ細胞療法と腫瘍溶解性ウイルス補助療法とを組み合わせる方法 | |
| JP2019532953A (ja) | 増強された有効性を有する免疫エフェクター細胞治療 | |
| CA3001859A1 (en) | Compositions and methods for inhibition of lineage specific antigens | |
| JP2021525067A5 (https=) | ||
| JP2021525068A5 (https=) | ||
| CN112867498A (zh) | 使用嵌合抗原受体基因组编辑和转导t细胞以用于治疗t和b细胞恶性肿瘤的方法 | |
| JP7227630B2 (ja) | Ｙ１８２ｔ突然変異を有するｔ細胞－抗原カプラおよびその方法ならびに使用 | |
| JP2021500878A (ja) | 免疫療法のためのｔ細胞受容体 | |
| JP7812549B2 (ja) | 人工免疫監視キメラ抗原受容体（ａｉ－ｃａｒ）及びそれを発現する細胞 | |
| JP2020536531A (ja) | 免疫療法としてのｐｄ１特異的キメラ抗原受容体 | |
| Danhof et al. | CARs and other T cell therapies for MM: the clinical experience | |
| KR20240116708A (ko) | 자연 살해 세포 및 이의 사용 방법 | |
| JP2021530971A (ja) | 様々な構築物最適化を備えたｔ細胞抗原カプラ | |
| JP2025525864A (ja) | ナチュラルキラー細胞の機能を増強するための標的遺伝子の遺伝子編集 | |
| Savani et al. | New targets for CAR T therapy in hematologic malignancies | |
| JP2024519614A (ja) | Ｐｒａｍｅ特異的ｔ細胞受容体とキメラ補助刺激受容体との組合せ | |
| CN112585162B (zh) | Ha-1特异性t细胞受体及其用途 | |
| EP4051317A1 (en) | Sequential anti-cd19 therapy | |
| CN109554349B (zh) | Pd-1基因表达沉默的工程化免疫细胞 | |
| KR20200118010A (ko) | 암의 만성 car 치료 | |
| JPWO2019226946A5 (https=) |